Vela I - Search Results

1

Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.

Porter LH, Zhu JJ, Lister NL, Harrison SG, Keerthikumar S, Goode DL, Urban RQ, Byrne DJ, Azad A, Vela I, Hofman MS, Neeson PJ, Darcy PK, Trapani JA, Taylor RA, Risbridger GP. Porter LH, et al. Among authors: vela i. Nat Commun. 2023 Sep 2;14(1):5346. doi: 10.1038/s41467-023-40852-3. Nat Commun. 2023. PMID: 37660083 Free PMC article.

2

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG. Perera M, et al. Among authors: vela i. Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14. Eur Urol. 2020. PMID: 30773328

3

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG; proPSMA Study Group Collaborators. Hofman MS, et al. Among authors: vela i. Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.

4

Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells.

Jaeschke A, Jacobi A, Lawrence MG, Risbridger GP, Frydenberg M, Williams ED, Vela I, Hutmacher DW, Bray LJ, Taubenberger A. Jaeschke A, et al. Among authors: vela i. Mater Today Bio. 2020 Aug 17;8:100073. doi: 10.1016/j.mtbio.2020.100073. eCollection 2020 Sep. Mater Today Bio. 2020. PMID: 32984808 Free PMC article.

5

UpFrontPSMA: a randomized phase 2 study of sequential ¹⁷⁷ Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol).

Dhiantravan N, Emmett L, Joshua AM, Pattison DA, Francis RJ, Williams S, Sandhu S, Davis ID, Vela I, Neha N, Bressel M, Murphy DG, Hofman MS, Azad AA. Dhiantravan N, et al. Among authors: vela i. BJU Int. 2021 Sep;128(3):331-342. doi: 10.1111/bju.15384. Epub 2021 Apr 21. BJU Int. 2021. PMID: 33682320

6

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer.

Perera MPJ, Thomas PB, Risbridger GP, Taylor R, Azad A, Hofman MS, Williams ED, Vela I. Perera MPJ, et al. Among authors: vela i. Cancers (Basel). 2022 Jan 20;14(3):503. doi: 10.3390/cancers14030503. Cancers (Basel). 2022. PMID: 35158771 Free PMC article. Review.

7

Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.

Thomas PB, Alinezhad S, Joshi A, Sweeney K, Tse BWC, Tevz G, McPherson S, Nelson CC, Williams ED, Vela I. Thomas PB, et al. Among authors: vela i. Curr Oncol. 2023 Oct 24;30(11):9437-9447. doi: 10.3390/curroncol30110683. Curr Oncol. 2023. PMID: 37999103 Free PMC article.

8

Bone and prostate cancer cell interactions in metastatic prostate cancer.

Vela I, Gregory L, Gardiner EM, Clements JA, Nicol DL. Vela I, et al. BJU Int. 2007 Apr;99(4):735-42. doi: 10.1111/j.1464-410X.2006.06670.x. Epub 2006 Dec 13. BJU Int. 2007. PMID: 17166237 Free article. Review.

9

Prostate cancer organoids: a potential new tool for testing drug sensitivity.

Vela I, Chen Y. Vela I, et al. Expert Rev Anticancer Ther. 2015 Mar;15(3):261-3. doi: 10.1586/14737140.2015.1003046. Epub 2015 Jan 20. Expert Rev Anticancer Ther. 2015. PMID: 25603995 Free PMC article.

10

Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand.

Ong WL, Thangasamy I, Murphy D, Pritchard E, Evans S, Millar J, Chalasani V, Rashid P, Winter M, Vela I, Pryor D, Mark S, Lawrentschuk N. Ong WL, et al. Among authors: vela i. BJU Int. 2022 Jun;130 Suppl 1(Suppl 1):17-19. doi: 10.1111/bju.15698. Epub 2022 Feb 21. BJU Int. 2022. PMID: 35076135 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page